Cancer immunotherapy: Microbes matter

Nature Reviews Drug Discovery 17, 16 (2018). doi:10.1038/nrd.2017.265 Author: Anna Dart Preclinical mouse models have shown that the gut microbiome can modulate therapeutic responses to cancer therapies. Yet, this has not been extensively characterized in humans. Two studies now propose that the gut microbiome is an important host factor that determines the response and primary resistance
Source: Nature Reviews Drug Discovery - Category: Drugs & Pharmacology Authors: Tags: Research Highlight Source Type: research